Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reversible male contraception by targeted inhibition of serine/threonine kinase 33

Science(2024)10.1126/science.adl2688Source: DataRank Database

Reversible male contraception by targeted inhibition of serine/threonine kinase 33 is a research paper published in Science (2024). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 5.54)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (30)

Kiran Sharma ORCID,Hai Minh Ta ORCID,Courtney M. Sutton ORCID,Kurt M. Bohren ORCID,Yong Wang ORCID

Live enrichment

PubMed:38781365 PMC:PMC11842024 OpenAlex:https://openalex.org/W4398250351

NIGMS NIH HHS

Grant: P30 GM124169

NICHD NIH HHS

Grant: R01 HD088412

NCI NIH HHS

Grant: R03 CA259664

NICHD NIH HHS

Grant: R33 HD099995

NIGMS NIH HHS

Grant: T32 GM139534

Gates Foundation

Grant: INV-001902

NIH HHS

Grant: S10 OD030246

FWCI

5.54

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

greenLicense: cc-by

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11842024/pdf/nihms-2052210.pdf

publisherhttps://www.science.org/doi/pdf/10.1126/science.adl2688

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11842024

journalhttps://doi.org/10.1126/science.adl2688

Fields of Study

Signaling Pathways in DiseaseGenomics and Chromatin DynamicsHIV/AIDS drug development and treatmentAnimalsHumansMaleMiceBlood-Testis BarrierContraceptive Agents, MaleProtein Kinase InhibitorsProtein Serine-Threonine KinasesSmall Molecule LibrariesTestisContraceptionStructure-Activity Relationship

MeSH Terms

AnimalsBlood-Testis BarrierContraceptionContraceptive Agents, MaleHumansMaleStructure-Activity RelationshipTestisProtein Serine-Threonine KinasesProtein Kinase InhibitorsMiceSmall Molecule Libraries

Keywords

SerineThreonineKinaseDNAPotencyBiologyChemistryPhosphorylationCell biologyBiochemistryIn vitro

Sustainable Development Goals

SDG 0: Good health and well-being

Reversible male contraception by targeted inhibition of serine/threonine kinase 33

FAIR Checklist

Authors (30)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)